Lung Cancer News

WHO updated its air quality database to include ground measurements of annual mean concentrations of nitrogen dioxide, as well as measurements of particulate matter with diameters equal to or smaller than 10 m or 2.5 m.

National Cancer Institute Director Norman E. “Ned” Sharpless, MD, announced Monday that he will step down from the position after nearly 5 years, according to an NCI press release.

Individuals whose underlying poor health may make them less likely to benefit from lung cancer screening appeared more likely to undergo the scans than those with better health status, according to study results in JAMA Network Open.

A blood-based signature of five microRNAs demonstrated the ability to predict OS of patients with lung cancer receiving immunotherapy and stratify them for treatment, according to a study published in npj Precision Oncology.

A randomized phase 3 trial designed to assess the addition of tiragolumab to atezolizumab and chemotherapy for extensive-stage small cell lung cancer failed to meet its co-primary endpoint of PFS.

The racial gap in timely surgery between Black and white patients with early-stage lung cancer improved after an antiracism intervention, according to study results published in Journal of Clinical Oncology.

The FDA issued a complete response letter indicating it cannot approve a biologics license application for sintilimab in combination with chemotherapy for first-line treatment of advanced nonsquamous non-small cell lung cancer.

Obesity and diffusing capacity of the lungs for carbon monoxide were significant risk factors for home oxygen use after pulmonary resection surgery, according to data published in Annals of the American Thoracic Society.

H. Jack West, MD, medical oncologist at City of Hope, spoke with Healio about AccessHope.

Healio spoke with Peter J. Mazzone, MD, MPH, director of the Lung Cancer Program and Lung Cancer Screening Program at the Cleveland Clinic Cancer Center Respiratory Institute, about how the 2021 changes to the USPSTF lung cancer screening guidelines have affected the number of patients being screened, improvements in patient outcomes and how specialists should continue to prepare for the effects of the updated guidelines.